Politically correct gene therapy? A 'clean environment' improves gene delivery to the brain!

Gene Therapy

Volumn 6, Issue 4, 1999, Pages 463-464

  Lowenstein, P R ^a   Thomas, C E ^a   Castro, M G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; BRAIN CELL; GENE TARGETING; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM DISEASES; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; SPECIFIC PATHOGEN-FREE ORGANISMS; TIME FACTORS; TRANSGENES;

ANIMALIA;

EID: 0032909037     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300917     Document Type: Short Survey

References (11)

1. Eck SL et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Human Gene Therapy 1996; 7: 1465-1482.
2. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Medicine 1997; 3: 1354-1361.
3. Aebischer P et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogenic cells in amyotrophic lateral sclerosis patients. Nature Medicine 1996; 2: 696-699.
4. Geddes BJ et al. Long term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine 1997; 3: 1402-1404.
5. Ghodsi A et al. Extensive β-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain. Human Gene Therapy 1998; 9: 2331-2340.
6. Byrnes AP et al. Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression and demyelination. Journal of Neuroscience 1996; 16: 3045-3055.
7. Stevenson PG et al. The immunogenicity of intracerebral virus infection depends on anatomical site. Journal of Virology 1997; 71: 145-151.
8. Cartmell T et al. Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. Journal of Neuroscience 1999; In Press.
9. Ohmoto Y et al. Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming. Gene Therapy 1999; 6: 471-481.
10. Kerschensteiner M et al. Activated human T cells, B cells and monocytes produce brain- derived neurotrophic factor (BDNF) in vitro and in brain lesions: A neuroprotective role of inflammation? Journal of Experimental Medicine 1999; In Press.
11. Moalem et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Medicine 1999; 5: 49-55.